Astragalus membranaceus (Astragaloside IV)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Astragalus membranaceus (Astragaloside IV).

Astragaloside IV acts as a potent cycloastragenol precursor and telomerase activator, exerting cytoprotective effects through the modulation of the PI3K/Akt/mTOR signaling pathway and reduction of oxidative stress-induced senescence.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

13943297

Molecular Weight

785.0 g/mol

XLogP3 (Lipophilicity)

1.3

IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-9-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Panax Ginseng for [synergistic immunomodulation and adaptogenic HPA-axis regulation]
Cycloastragenol for [complementary telomerase activation and cellular longevity signaling]

Biological Formulation Enhancers

Piperine for [inhibition of P-glycoprotein-mediated efflux to increase intestinal permeability]
Quercetin for [synergistic antioxidant protection and potential inhibition of phase II metabolism]

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Astragalus membranaceus (Astragaloside IV) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Astragalus extracts requires moisture-resistant HPMC capsules and desiccants to prevent clumping and degradation of the saponin content.

🍬 Gummy & Pectin Formats

High concentrations of Astragaloside IV can impart a distinct bitter, earthy profile that requires complex flavor masking and may interfere with the pectin gelation matrix if not properly buffered.

🔬 Thin-Film Oral Strips

The high therapeutic dosage required for crude extracts versus the low payload capacity of thin-film polymers necessitates the use of highly purified Astragaloside IV isolates to maintain film integrity.

For Brand Founders

Formulate with Astragalus membranaceus (Astragaloside IV)

Ready to launch a product featuring Astragalus membranaceus (Astragaloside IV)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Astragalus membranaceus (Astragaloside IV) Bioavailability

Need absolute proof that your Astragalus membranaceus (Astragaloside IV) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Astragalus membranaceus (Astragaloside IV) Degradation Testing

Is your Astragalus membranaceus (Astragaloside IV) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation